Terveystalo, Finland's leading healthcare provider, has integrated Nightingale Health’s advanced blood analysis technology into its routine occupational health assessments. This update is now active for all of Terveystalo’s occupational health clients nationwide, as the company has an exclusive partnership with Nightingale Health in Finland.

The collaboration, announced in August 2023, has seamlessly merged Nightingale Health’s disease risk assessments and diagnostic blood values into Terveystalo’s daily occupational health services. This integration spans Terveystalo locations across Finland, ensuring swift healthcare responses.

Serving over 27,000 companies and organizations, encompassing approximately 700,000 employees, Terveystalo operates more than 370 clinics across the country. Nightingale Health's blood biomarker-based assessments, incorporated into Terveystalo’s health checks, now identify risks for eight common chronic diseases from a single blood sample. This technological advancement significantly enhances the potential for disease prevention during regular health assessments.

Source: nightingalehealth.com